Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study
AimsTo determine myopia progression in children who continued to wear the defocus incorporated multiple segments (DIMS) lenses or switched from single vision (SV) to DIMS lenses for a 1-year period following a 2-year myopia control trial.Methods128 children participated in this study. The children w...
Gespeichert in:
| Veröffentlicht in: | British journal of ophthalmology Jg. 106; H. 8; S. 1110 - 1114 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
BMA House, Tavistock Square, London, WC1H 9JR
BMJ Publishing Group Ltd
01.08.2022
BMJ Publishing Group LTD BMJ Publishing Group |
| Schlagworte: | |
| ISSN: | 0007-1161, 1468-2079, 1468-2079 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | AimsTo determine myopia progression in children who continued to wear the defocus incorporated multiple segments (DIMS) lenses or switched from single vision (SV) to DIMS lenses for a 1-year period following a 2-year myopia control trial.Methods128 children participated in this study. The children who had worn DIMS lenses continued to wear DIMS lenses (DIMS group), and children who had worn SV lenses switched to wear DIMS lenses (Control-to-DIMS group). Cycloplegic spherical equivalent refraction (SER) and axial length (AL) were measured at 6-month interval. Historical controls were age matched to the DIMS group at 24 months and used for comparing the third-year changes.ResultsOver 3 years, SER and AL changes in the DIMS group (n=65) were −0.52±0.69D and 0.31±0.26 mm; these changes were not statistically significant over time (repeated measures analysis of variance, p>0.05).SER (−0.04±0. 38D) and AL (0.08±0.12 mm) changes in the Control-to-DIMS group (n=55) in the third year were less compared with the first (mean difference=0.45 ± 0.30D, 0.21±0.11 mm, p<0.001) and second (0.34±0.30D, 0.12±0.10 mm, p<0.001) years.Changes in SER and AL in both groups over that period were significantly less than in the historical control group (DIMS vs historical control: mean difference=−0.18±0.42D, p=0.012; 0.08±0.15 mm, p=0.001; Control-to-DIMS versus historical control: adjusted mean differences=−0.30±0.42D, p<0.001; 0.12±0.16 mm, p<0.001).ConclusionsMyopia control effect was sustained in the third year in children who had used the DIMS spectacles in the previous 2 years and was also shown in the children switching from SV to DIMS lenses. |
|---|---|
| AbstractList | To determine myopia progression in children who continued to wear the defocus incorporated multiple segments (DIMS) lenses or switched from single vision (SV) to DIMS lenses for a 1-year period following a 2-year myopia control trial.
128 children participated in this study. The children who had worn DIMS lenses continued to wear DIMS lenses (DIMS group), and children who had worn SV lenses switched to wear DIMS lenses (Control-to-DIMS group). Cycloplegic spherical equivalent refraction (SER) and axial length (AL) were measured at 6-month interval. Historical controls were age matched to the DIMS group at 24 months and used for comparing the third-year changes.
Over 3 years, SER and AL changes in the DIMS group (n=65) were -0.52±0.69D and 0.31±0.26 mm; these changes were not statistically significant over time (repeated measures analysis of variance, p>0.05).SER (-0.04±0. 38D) and AL (0.08±0.12 mm) changes in the Control-to-DIMS group (n=55) in the third year were less compared with the first (mean difference=0.45 ± 0.30D, 0.21±0.11 mm, p<0.001) and second (0.34±0.30D, 0.12±0.10 mm, p<0.001) years.Changes in SER and AL in both groups over that period were significantly less than in the historical control group (DIMS vs historical control: mean difference=-0.18±0.42D, p=0.012; 0.08±0.15 mm, p=0.001; Control-to-DIMS versus historical control: adjusted mean differences=-0.30±0.42D, p<0.001; 0.12±0.16 mm, p<0.001).
Myopia control effect was sustained in the third year in children who had used the DIMS spectacles in the previous 2 years and was also shown in the children switching from SV to DIMS lenses. AimsTo determine myopia progression in children who continued to wear the defocus incorporated multiple segments (DIMS) lenses or switched from single vision (SV) to DIMS lenses for a 1-year period following a 2-year myopia control trial.Methods128 children participated in this study. The children who had worn DIMS lenses continued to wear DIMS lenses (DIMS group), and children who had worn SV lenses switched to wear DIMS lenses (Control-to-DIMS group). Cycloplegic spherical equivalent refraction (SER) and axial length (AL) were measured at 6-month interval. Historical controls were age matched to the DIMS group at 24 months and used for comparing the third-year changes.ResultsOver 3 years, SER and AL changes in the DIMS group (n=65) were −0.52±0.69D and 0.31±0.26 mm; these changes were not statistically significant over time (repeated measures analysis of variance, p>0.05).SER (−0.04±0. 38D) and AL (0.08±0.12 mm) changes in the Control-to-DIMS group (n=55) in the third year were less compared with the first (mean difference=0.45 ± 0.30D, 0.21±0.11 mm, p<0.001) and second (0.34±0.30D, 0.12±0.10 mm, p<0.001) years.Changes in SER and AL in both groups over that period were significantly less than in the historical control group (DIMS vs historical control: mean difference=−0.18±0.42D, p=0.012; 0.08±0.15 mm, p=0.001; Control-to-DIMS versus historical control: adjusted mean differences=−0.30±0.42D, p<0.001; 0.12±0.16 mm, p<0.001).ConclusionsMyopia control effect was sustained in the third year in children who had used the DIMS spectacles in the previous 2 years and was also shown in the children switching from SV to DIMS lenses. To determine myopia progression in children who continued to wear the defocus incorporated multiple segments (DIMS) lenses or switched from single vision (SV) to DIMS lenses for a 1-year period following a 2-year myopia control trial.AIMSTo determine myopia progression in children who continued to wear the defocus incorporated multiple segments (DIMS) lenses or switched from single vision (SV) to DIMS lenses for a 1-year period following a 2-year myopia control trial.128 children participated in this study. The children who had worn DIMS lenses continued to wear DIMS lenses (DIMS group), and children who had worn SV lenses switched to wear DIMS lenses (Control-to-DIMS group). Cycloplegic spherical equivalent refraction (SER) and axial length (AL) were measured at 6-month interval. Historical controls were age matched to the DIMS group at 24 months and used for comparing the third-year changes.METHODS128 children participated in this study. The children who had worn DIMS lenses continued to wear DIMS lenses (DIMS group), and children who had worn SV lenses switched to wear DIMS lenses (Control-to-DIMS group). Cycloplegic spherical equivalent refraction (SER) and axial length (AL) were measured at 6-month interval. Historical controls were age matched to the DIMS group at 24 months and used for comparing the third-year changes.Over 3 years, SER and AL changes in the DIMS group (n=65) were -0.52±0.69D and 0.31±0.26 mm; these changes were not statistically significant over time (repeated measures analysis of variance, p>0.05).SER (-0.04±0. 38D) and AL (0.08±0.12 mm) changes in the Control-to-DIMS group (n=55) in the third year were less compared with the first (mean difference=0.45 ± 0.30D, 0.21±0.11 mm, p<0.001) and second (0.34±0.30D, 0.12±0.10 mm, p<0.001) years.Changes in SER and AL in both groups over that period were significantly less than in the historical control group (DIMS vs historical control: mean difference=-0.18±0.42D, p=0.012; 0.08±0.15 mm, p=0.001; Control-to-DIMS versus historical control: adjusted mean differences=-0.30±0.42D, p<0.001; 0.12±0.16 mm, p<0.001).RESULTSOver 3 years, SER and AL changes in the DIMS group (n=65) were -0.52±0.69D and 0.31±0.26 mm; these changes were not statistically significant over time (repeated measures analysis of variance, p>0.05).SER (-0.04±0. 38D) and AL (0.08±0.12 mm) changes in the Control-to-DIMS group (n=55) in the third year were less compared with the first (mean difference=0.45 ± 0.30D, 0.21±0.11 mm, p<0.001) and second (0.34±0.30D, 0.12±0.10 mm, p<0.001) years.Changes in SER and AL in both groups over that period were significantly less than in the historical control group (DIMS vs historical control: mean difference=-0.18±0.42D, p=0.012; 0.08±0.15 mm, p=0.001; Control-to-DIMS versus historical control: adjusted mean differences=-0.30±0.42D, p<0.001; 0.12±0.16 mm, p<0.001).Myopia control effect was sustained in the third year in children who had used the DIMS spectacles in the previous 2 years and was also shown in the children switching from SV to DIMS lenses.CONCLUSIONSMyopia control effect was sustained in the third year in children who had used the DIMS spectacles in the previous 2 years and was also shown in the children switching from SV to DIMS lenses. |
| Author | Lam, Carly SY Tang, Wing Chun Qi, Hua Lee, Paul H Zhang, Han Yu Hasegawa, Keigo To, Chi Ho |
| AuthorAffiliation | 1 Centre for Myopia Research, School of Optometry , The Hong Kong Polytechnic University , Kowloon , Hong Kong 3 School of Nursing , The Hong Kong Polytechnic University , Kowloon , Hong Kong 2 Centre for Eye and Vision Research (CEVR) , Hong Kong , Hong Kong 4 Technical Research & Development Department , Hoya Corporation Vision Care Section , Shinjuku-ku , Tokyo , Japan |
| AuthorAffiliation_xml | – name: 2 Centre for Eye and Vision Research (CEVR) , Hong Kong , Hong Kong – name: 1 Centre for Myopia Research, School of Optometry , The Hong Kong Polytechnic University , Kowloon , Hong Kong – name: 3 School of Nursing , The Hong Kong Polytechnic University , Kowloon , Hong Kong – name: 4 Technical Research & Development Department , Hoya Corporation Vision Care Section , Shinjuku-ku , Tokyo , Japan |
| Author_xml | – sequence: 1 givenname: Carly SY orcidid: 0000-0002-6808-5018 surname: Lam fullname: Lam, Carly SY email: carly.lam@polyu.edu.hk organization: Centre for Eye and Vision Research (CEVR), Hong Kong, Hong Kong – sequence: 2 givenname: Wing Chun surname: Tang fullname: Tang, Wing Chun organization: Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong – sequence: 3 givenname: Paul H orcidid: 0000-0002-5729-6450 surname: Lee fullname: Lee, Paul H organization: School of Nursing, The Hong Kong Polytechnic University, Kowloon, Hong Kong – sequence: 4 givenname: Han Yu orcidid: 0000-0003-4932-1887 surname: Zhang fullname: Zhang, Han Yu organization: Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong – sequence: 5 givenname: Hua surname: Qi fullname: Qi, Hua organization: Technical Research & Development Department, Hoya Corporation Vision Care Section, Shinjuku-ku, Tokyo, Japan – sequence: 6 givenname: Keigo surname: Hasegawa fullname: Hasegawa, Keigo organization: Technical Research & Development Department, Hoya Corporation Vision Care Section, Shinjuku-ku, Tokyo, Japan – sequence: 7 givenname: Chi Ho surname: To fullname: To, Chi Ho organization: Centre for Eye and Vision Research (CEVR), Hong Kong, Hong Kong |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33731364$$D View this record in MEDLINE/PubMed |
| BookMark | eNqVUs1u1DAYtFAR3S68ArLEpRwCdpw4CQekavmr1IoDvVuO87nrlWMH2wHtS_DMONqyLVyAk2V_M-NvNHOGTpx3gBCm5BWljL_ud37apq20o7dFSUpSMNpwXj1CK1rxNj813QlaEUKaglJOT9FZjLt8LTltnqBTxhqWdaoV-nG995ORWHmXgrcYtAaVsNd4AO3VHLFxyofJB5lgwONsk5ks4Ai3I7gU8fm7y-svL3GcMk2qPLHgFhLebI2DCFhtjR0CuDc4QMz0uIhLzIo9yIC1t9Z_L-YJxzQP-6fosZY2wrO7c41uPry_2Xwqrj5_vNxcXBV9zZpUcF4q2tWlhq7kjaqg7qkGCm2r27IHpSVT9VBmm73kA60lAap6puSgh5Y2bI3eHmSnuR9hUNlJkFZMwYwy7IWXRvw-cWYrbv030bGKEMaywPmdQPBfZ4hJjCYqsFY68HMUZU3KlnS0Ixn64g_ozs_BZXei5B2jdcVzpmv0_OFGx1V-JZUB7QGggo8xgD5CKBFLKcTDUoilFOJQinu3R6oySSazRC6N_RcBdhDox93_fFvds46e_0r7CVPI6GI |
| CitedBy_id | crossref_primary_10_1186_s12886_024_03666_5 crossref_primary_10_1136_bmjopen_2022_068822 crossref_primary_10_3389_fmed_2023_1207328 crossref_primary_10_1038_s41598_025_91089_7 crossref_primary_10_21516_2072_0076_2025_18_3_50_56 crossref_primary_10_1136_bmjophth_2022_000971 crossref_primary_10_1007_s10792_023_02788_x crossref_primary_10_3389_fpubh_2023_1125000 crossref_primary_10_2147_OPTH_S370041 crossref_primary_10_1136_bjo_2024_326116 crossref_primary_10_1186_s12886_022_02440_9 crossref_primary_10_1364_BOE_559666 crossref_primary_10_3390_jcm11092294 crossref_primary_10_1016_j_clae_2022_101703 crossref_primary_10_3389_fmed_2024_1416286 crossref_primary_10_18502_jovr_v18i4_14544 crossref_primary_10_1111_aos_15649 crossref_primary_10_1038_s41598_022_15686_6 crossref_primary_10_1155_2022_1004977 crossref_primary_10_1007_s40123_025_01214_y crossref_primary_10_1038_s41598_024_78300_x crossref_primary_10_1136_bjo_2023_323680 crossref_primary_10_1038_s41433_023_02625_6 crossref_primary_10_1038_s41433_023_02629_2 crossref_primary_10_71413_4ex9a861 crossref_primary_10_1136_bjo_2021_321005 crossref_primary_10_3389_fmed_2025_1524700 crossref_primary_10_3341_kjo_2022_0125 crossref_primary_10_1136_bjo_2024_326852 crossref_primary_10_1136_bmjophth_2025_002142 crossref_primary_10_2147_OPTH_S541232 crossref_primary_10_1364_BOE_558990 crossref_primary_10_1016_j_optom_2023_100505 crossref_primary_10_3389_fphar_2024_1503536 crossref_primary_10_1016_j_clae_2025_102508 crossref_primary_10_3389_fped_2022_889243 crossref_primary_10_1007_s00347_021_01452_y crossref_primary_10_1136_bjo_2023_324508 crossref_primary_10_1136_bjo_2023_324347 crossref_primary_10_1055_a_1927_5631 crossref_primary_10_1001_jamaophthalmol_2025_2072 crossref_primary_10_1038_s41598_023_37454_w crossref_primary_10_3390_vision6020020 crossref_primary_10_12677_HJO_2023_122012 crossref_primary_10_1016_j_ajo_2023_03_030 crossref_primary_10_3390_ijerph19127270 crossref_primary_10_1007_s40123_025_01195_y crossref_primary_10_1016_j_ophtha_2021_11_023 crossref_primary_10_1136_bmjophth_2023_001499 crossref_primary_10_1038_s41598_023_30157_2 crossref_primary_10_3389_fnins_2024_1460062 crossref_primary_10_7759_cureus_92934 crossref_primary_10_3389_fpubh_2023_1074272 crossref_primary_10_1097_APO_0000000000000489 |
| Cites_doi | 10.1038/eye.2013.256 10.1136/bjophthalmol-2018-313739 10.1001/jama.2020.10834 10.1136/bjophthalmol-2013-303914 10.1167/iovs.11-7260 10.1089/jop.2015.0043 10.1097/OPX.0000000000001410 10.1016/S0161-6420(01)01024-7 10.1167/iovs.12-10565 10.1016/j.ophtha.2011.07.031 10.1016/j.ophtha.2018.05.029 10.1167/iovs.11-8005 10.1016/j.ophtha.2006.06.050 10.1111/j.1475-1313.2011.00886.x 10.2147/AHMT.S55834 10.1097/OPX.0000000000000808 10.1001/jamaophthalmol.2013.7623 10.1167/iovs.11-8453 10.1016/j.ophtha.2015.11.010 10.1111/opo.12082 10.1016/S0140-6736(12)60272-4 10.1097/OPX.0000000000000036 10.1016/j.ophtha.2016.01.006 10.2471/BLT.12.104034 10.1016/j.ophtha.2006.05.062 |
| ContentType | Journal Article |
| Copyright | Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 |
| Copyright_xml | – notice: Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. – notice: Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 |
| DBID | 9YT ACMMV AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR BTHHO CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM |
| DOI | 10.1136/bjophthalmol-2020-317664 |
| DatabaseName | BMJ Open Access Journals BMJ Journals:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central BMJ Journals ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection PML(ProQuest Medical Library) ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) BMJ Journals Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest One Academic Middle East (New) |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1468-2079 |
| EndPage | 1114 |
| ExternalDocumentID | PMC9340033 33731364 10_1136_bjophthalmol_2020_317664 bjophthalmol |
| Genre | Research Support, Non-U.S. Gov't Controlled Clinical Trial Journal Article |
| GeographicLocations | China Hong Kong |
| GeographicLocations_xml | – name: China – name: Hong Kong |
| GrantInformation_xml | – fundername: Hoya Corporation, Japan grantid: ZG5N – fundername: HK PolyU grantid: ZE1A – fundername: Dean's Research, Faculty of Health and Social Sciences grantid: ZVN1 – fundername: Henry G. Leong Endowed Profesorsip grantid: 8-8475 – fundername: RGC Research Impact Fund grantid: R5032-18 – fundername: Dean's Reserve, Faculty of Health and Social Sciences grantid: ZVN2 – fundername: ; grantid: 8-8475 – fundername: ; grantid: R5032-18 – fundername: ; grantid: ZVN2 – fundername: ; grantid: ZE1A – fundername: ; grantid: ZVN1 – fundername: ; grantid: ZG5N |
| GroupedDBID | --- -~X .55 .GJ .VT 0R~ 18M 23N 2WC 354 39C 3O- 4.4 40O 53G 5GY 5RE 5VS 6J9 7X7 7~S 88E 8FI 8FJ 8R4 8R5 9YT AAHLL AAKAS AAOJX AAWJN ABAAH ABJNI ABKDF ABMQD ABTFR ABUWG ABVAJ ACCCW ACGFO ACGFS ACGTL ACHTP ACMFJ ACMMV ACNCT ACOAB ACOFX ACQSR ACTZY ADBBV ADCEG ADZCM AENEX AFKRA AFWFF AGQPQ AHMBA AHNKE AHQMW AJYBZ ALIPV ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AZFZN BAWUL BENPR BLJBA BOMFT BPHCQ BTFSW BTHHO BVXVI C1A C45 CAG CCPQU COF CS3 CXRWF DIK DU5 E3Z EBS EJD F5P FYUFA H13 HAJ HMCUK HYE HZ~ IAO IEA IHR IOF ITC J5H KQ8 L7B M1P N9A NTWIH NXWIF O9- OK1 OVD P2P PHGZT PQQKQ PROAC PSQYO Q2X R53 RHI RMJ RPM RV8 TEORI TR2 UAW UKHRP UYXKK V24 VM9 W8F WH7 WOQ X7M XOL YFH YQY ZGI AAYXX ACQHZ AERUA AFFHD CITATION PHGZM PJZUB PPXIY AAFWJ CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK K9. PKEHL PQEST PQUKI 7X8 5PM |
| ID | FETCH-LOGICAL-b537t-662c1952fe9267c4e5b1fe1e88f82becfa3c5d2337ba6d15a0e1cb3cadfd8173 |
| IEDL.DBID | BENPR |
| ISICitedReferencesCount | 150 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000728111500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0007-1161 1468-2079 |
| IngestDate | Tue Nov 04 01:49:07 EST 2025 Sun Nov 09 13:19:55 EST 2025 Tue Oct 07 07:20:38 EDT 2025 Thu Nov 13 04:44:08 EST 2025 Sat Nov 29 03:06:08 EST 2025 Tue Nov 18 22:19:30 EST 2025 Thu Apr 24 22:50:16 EDT 2025 Thu Apr 24 22:50:00 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Keywords | clinical trial child health (paediatrics) |
| Language | English |
| License | This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b537t-662c1952fe9267c4e5b1fe1e88f82becfa3c5d2337ba6d15a0e1cb3cadfd8173 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
| ORCID | 0000-0002-5729-6450 0000-0003-4932-1887 0000-0002-6808-5018 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC9340033 |
| PMID | 33731364 |
| PQID | 2693154611 |
| PQPubID | 2041039 |
| PageCount | 5 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9340033 proquest_miscellaneous_2502809190 proquest_journals_2693154611 pubmed_primary_33731364 crossref_primary_10_1136_bjophthalmol_2020_317664 crossref_citationtrail_10_1136_bjophthalmol_2020_317664 bmj_primary_10_1136_bjophthalmol_2020_317664 bmj_journals_10_1136_bjophthalmol_2020_317664 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-08-01 |
| PublicationDateYYYYMMDD | 2022-08-01 |
| PublicationDate_xml | – month: 08 year: 2022 text: 2022-08-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | BMA House, Tavistock Square, London, WC1H 9JR |
| PublicationPlace_xml | – name: BMA House, Tavistock Square, London, WC1H 9JR – name: England – name: London |
| PublicationTitle | British journal of ophthalmology |
| PublicationTitleAbbrev | Br J Ophthalmol |
| PublicationTitleAlternate | Br J Ophthalmol |
| PublicationYear | 2022 |
| Publisher | BMJ Publishing Group Ltd BMJ Publishing Group LTD BMJ Publishing Group |
| Publisher_xml | – name: BMJ Publishing Group Ltd – name: BMJ Publishing Group LTD – name: BMJ Publishing Group |
| References | Holden, Sankaridurg, Smith (R7) 2014; 28 Cheng, Woo, Drobe (R19) 2014; 132 Chua, Balakrishnan, Chan (R12) 2006; 113 Lam, Lam, Cheng (R3) 2012; 32 Walline, Greiner, McVey (R23) 2013; 90 Chia, Chua, Cheung (R13) 2012; 119 Smith, Walline (R10) 2015; 6 Sankaridurg, Holden, Smith (R20) 2011; 52 Walline, Walker, Mutti (R26) 2020; 324 Yam, Jiang, Tang (R15) 2019; 126 Aller, Liu, Wildsoet (R22) 2016; 93 Lam, Tang, Tse (R25) 2020; 104 Cho, Cheung (R16) 2012; 53 Fricke, Holden, Wilson (R8) 2012; 90 Vongphanit, Mitchell, Wang (R4) 2002; 109 Xu, Wang, Wang (R6) 2007; 114 Clark, Clark (R14) 2015; 31 Holden, Fricke, Wilson (R2) 2016; 123 Lam, Tang, Tse (R21) 2014; 98 Morgan, Ohno-Matsui, Saw (R1) 2012; 379 Santodomingo-Rubido, Villa-Collar, Gilmartin (R18) 2012; 53 Hiraoka, Kakita, Okamoto (R17) 2012; 53 Chamberlain, Peixoto-de-Matos, Logan (R24) 2019; 96 Huang, Wen, Wang (R9) 2016; 123 Cheng, Lam, Yap (R5) 2013; 33 Hiraoka, Kakita, Okamoto 2012; 53 Santodomingo-Rubido, Villa-Collar, Gilmartin 2012; 53 Lam, Lam, Cheng 2012; 32 Smith, Walline 2015; 6 Lam, Tang, Tse 2020; 104 Holden, Fricke, Wilson 2016; 123 Vongphanit, Mitchell, Wang 2002; 109 Aller, Liu, Wildsoet 2016; 93 Holden, Sankaridurg, Smith 2014; 28 Yam, Jiang, Tang 2019; 126 Walline, Walker, Mutti 2020; 324 Chia, Chua, Cheung 2012; 119 Cho, Cheung 2012; 53 Cheng, Woo, Drobe 2014; 132 Chamberlain, Peixoto-de-Matos, Logan 2019; 96 Huang, Wen, Wang 2016; 123 Cheng, Lam, Yap 2013; 33 Xu, Wang, Wang 2007; 114 Clark, Clark 2015; 31 Morgan, Ohno-Matsui, Saw 2012; 379 Chua, Balakrishnan, Chan 2006; 113 Fricke, Holden, Wilson 2012; 90 Lam, Tang, Tse 2014; 98 Sankaridurg, Holden, Smith 2011; 52 Walline, Greiner, McVey 2013; 90 Walline (2021031710251102000_bjophthalmol-2020-317664v1.26) 2020; 324 Walline (2021031710251102000_bjophthalmol-2020-317664v1.23) 2013; 90 2021031710251102000_bjophthalmol-2020-317664v1.11 2021031710251102000_bjophthalmol-2020-317664v1.4 2021031710251102000_bjophthalmol-2020-317664v1.16 2021031710251102000_bjophthalmol-2020-317664v1.3 2021031710251102000_bjophthalmol-2020-317664v1.17 2021031710251102000_bjophthalmol-2020-317664v1.6 2021031710251102000_bjophthalmol-2020-317664v1.18 2021031710251102000_bjophthalmol-2020-317664v1.5 2021031710251102000_bjophthalmol-2020-317664v1.12 2021031710251102000_bjophthalmol-2020-317664v1.13 2021031710251102000_bjophthalmol-2020-317664v1.2 2021031710251102000_bjophthalmol-2020-317664v1.14 2021031710251102000_bjophthalmol-2020-317664v1.1 2021031710251102000_bjophthalmol-2020-317664v1.15 2021031710251102000_bjophthalmol-2020-317664v1.8 2021031710251102000_bjophthalmol-2020-317664v1.9 2021031710251102000_bjophthalmol-2020-317664v1.20 2021031710251102000_bjophthalmol-2020-317664v1.21 Holden (2021031710251102000_bjophthalmol-2020-317664v1.7) 2014; 28 Smith (2021031710251102000_bjophthalmol-2020-317664v1.10) 2015; 6 Cheng (2021031710251102000_bjophthalmol-2020-317664v1.19) 2014; 132 2021031710251102000_bjophthalmol-2020-317664v1.25 Aller (2021031710251102000_bjophthalmol-2020-317664v1.22) 2016; 93 Chamberlain (2021031710251102000_bjophthalmol-2020-317664v1.24) 2019; 96 |
| References_xml | – volume: 28 start-page: 142 year: 2014 ident: R7 article-title: Myopia, an underrated global challenge to vision: where the current data takes us on myopia control publication-title: Eye doi: 10.1038/eye.2013.256 – volume: 104 start-page: 363 year: 2020 ident: R25 article-title: Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2018-313739 – volume: 324 start-page: 571 year: 2020 ident: R26 article-title: Effect of high add power, medium add power, or single-vision contact lenses on myopia progression in children: the blink randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2020.10834 – volume: 98 start-page: 40 year: 2014 ident: R21 article-title: Defocus incorporated soft contact (disc) lens slows myopia progression in Hong Kong Chinese schoolchildren: a 2-year randomised clinical trial publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2013-303914 – volume: 52 start-page: 9362 year: 2011 ident: R20 article-title: Decrease in rate of myopia progression with a contact lens designed to reduce relative peripheral hyperopia: one-year results publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.11-7260 – volume: 31 start-page: 541 year: 2015 ident: R14 article-title: Atropine 0.01% Eyedrops significantly reduce the progression of childhood myopia publication-title: J Ocul Pharmacol Ther doi: 10.1089/jop.2015.0043 – volume: 96 start-page: 556 year: 2019 ident: R24 article-title: A 3-year randomized clinical trial of MiSight lenses for myopia control publication-title: Optom Vis Sci doi: 10.1097/OPX.0000000000001410 – volume: 109 start-page: 704 year: 2002 ident: R4 article-title: Prevalence and progression of myopic retinopathy in an older population publication-title: Ophthalmology doi: 10.1016/S0161-6420(01)01024-7 – volume: 53 start-page: 7077 year: 2012 ident: R16 article-title: Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.12-10565 – volume: 119 start-page: 347 year: 2012 ident: R13 article-title: Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2) publication-title: Ophthalmology doi: 10.1016/j.ophtha.2011.07.031 – volume: 126 start-page: 113 year: 2019 ident: R15 article-title: Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control publication-title: Ophthalmology doi: 10.1016/j.ophtha.2018.05.029 – volume: 53 start-page: 5060 year: 2012 ident: R18 article-title: Myopia control with orthokeratology contact lenses in Spain: refractive and biometric changes publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.11-8005 – volume: 114 start-page: 216 year: 2007 ident: R6 article-title: High myopia and glaucoma susceptibility the Beijing eye study publication-title: Ophthalmology doi: 10.1016/j.ophtha.2006.06.050 – volume: 32 start-page: 17 year: 2012 ident: R3 article-title: Prevalence of myopia among Hong Kong Chinese schoolchildren: changes over two decades publication-title: Ophthalmic Physiol Opt doi: 10.1111/j.1475-1313.2011.00886.x – volume: 6 start-page: 133 year: 2015 ident: R10 article-title: Controlling myopia progression in children and adolescents publication-title: Adolesc Health Med Ther doi: 10.2147/AHMT.S55834 – volume: 93 start-page: 344 year: 2016 ident: R22 article-title: Myopia control with bifocal contact lenses: a randomized clinical trial publication-title: Optom Vis Sci doi: 10.1097/OPX.0000000000000808 – volume: 132 start-page: 258 year: 2014 ident: R19 article-title: Effect of bifocal and prismatic bifocal spectacles on myopia progression in children: three-year results of a randomized clinical trial publication-title: JAMA Ophthalmol doi: 10.1001/jamaophthalmol.2013.7623 – volume: 53 start-page: 3913 year: 2012 ident: R17 article-title: Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia: a 5-year follow-up study publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.11-8453 – volume: 123 start-page: 697 year: 2016 ident: R9 article-title: Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis publication-title: Ophthalmology doi: 10.1016/j.ophtha.2015.11.010 – volume: 33 start-page: 652 year: 2013 ident: R5 article-title: Prevalence of myopia-related retinal changes among 12-18 year old Hong Kong Chinese high myopes publication-title: Ophthalmic Physiol Opt doi: 10.1111/opo.12082 – volume: 379 start-page: 1739 year: 2012 ident: R1 article-title: Myopia publication-title: Lancet doi: 10.1016/S0140-6736(12)60272-4 – volume: 90 start-page: 1207 year: 2013 ident: R23 article-title: Multifocal contact lens myopia control publication-title: Optom Vis Sci doi: 10.1097/OPX.0000000000000036 – volume: 123 start-page: 1036 year: 2016 ident: R2 article-title: Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050 publication-title: Ophthalmology doi: 10.1016/j.ophtha.2016.01.006 – volume: 90 start-page: 728 year: 2012 ident: R8 article-title: Global cost of correcting vision impairment from uncorrected refractive error publication-title: Bull World Health Organ doi: 10.2471/BLT.12.104034 – volume: 113 start-page: 2285 year: 2006 ident: R12 article-title: Atropine for the treatment of childhood myopia publication-title: Ophthalmology doi: 10.1016/j.ophtha.2006.05.062 – volume: 324 start-page: 571 year: 2020 article-title: Effect of high add power, medium add power, or single-vision contact lenses on myopia progression in children: the blink randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2020.10834 – volume: 132 start-page: 258 year: 2014 article-title: Effect of bifocal and prismatic bifocal spectacles on myopia progression in children: three-year results of a randomized clinical trial publication-title: JAMA Ophthalmol doi: 10.1001/jamaophthalmol.2013.7623 – volume: 123 start-page: 697 year: 2016 article-title: Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis publication-title: Ophthalmology doi: 10.1016/j.ophtha.2015.11.010 – volume: 93 start-page: 344 year: 2016 article-title: Myopia control with bifocal contact lenses: a randomized clinical trial publication-title: Optom Vis Sci doi: 10.1097/OPX.0000000000000808 – volume: 28 start-page: 142 year: 2014 article-title: Myopia, an underrated global challenge to vision: where the current data takes us on myopia control publication-title: Eye doi: 10.1038/eye.2013.256 – volume: 33 start-page: 652 year: 2013 article-title: Prevalence of myopia-related retinal changes among 12-18 year old Hong Kong Chinese high myopes publication-title: Ophthalmic Physiol Opt doi: 10.1111/opo.12082 – volume: 6 start-page: 133 year: 2015 article-title: Controlling myopia progression in children and adolescents publication-title: Adolesc Health Med Ther doi: 10.2147/AHMT.S55834 – volume: 90 start-page: 728 year: 2012 article-title: Global cost of correcting vision impairment from uncorrected refractive error publication-title: Bull World Health Organ doi: 10.2471/BLT.12.104034 – volume: 104 start-page: 363 year: 2020 article-title: Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2018-313739 – volume: 96 start-page: 556 year: 2019 article-title: A 3-year randomized clinical trial of MiSight lenses for myopia control publication-title: Optom Vis Sci doi: 10.1097/OPX.0000000000001410 – volume: 53 start-page: 5060 year: 2012 article-title: Myopia control with orthokeratology contact lenses in Spain: refractive and biometric changes publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.11-8005 – volume: 123 start-page: 1036 year: 2016 article-title: Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050 publication-title: Ophthalmology doi: 10.1016/j.ophtha.2016.01.006 – volume: 32 start-page: 17 year: 2012 article-title: Prevalence of myopia among Hong Kong Chinese schoolchildren: changes over two decades publication-title: Ophthalmic Physiol Opt doi: 10.1111/j.1475-1313.2011.00886.x – volume: 119 start-page: 347 year: 2012 article-title: Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2) publication-title: Ophthalmology doi: 10.1016/j.ophtha.2011.07.031 – volume: 53 start-page: 3913 year: 2012 article-title: Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia: a 5-year follow-up study publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.11-8453 – volume: 109 start-page: 704 year: 2002 article-title: Prevalence and progression of myopic retinopathy in an older population publication-title: Ophthalmology doi: 10.1016/S0161-6420(01)01024-7 – volume: 52 start-page: 9362 year: 2011 article-title: Decrease in rate of myopia progression with a contact lens designed to reduce relative peripheral hyperopia: one-year results publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.11-7260 – volume: 113 start-page: 2285 year: 2006 article-title: Atropine for the treatment of childhood myopia publication-title: Ophthalmology doi: 10.1016/j.ophtha.2006.05.062 – volume: 31 start-page: 541 year: 2015 article-title: Atropine 0.01% Eyedrops significantly reduce the progression of childhood myopia publication-title: J Ocul Pharmacol Ther doi: 10.1089/jop.2015.0043 – volume: 114 start-page: 216 year: 2007 article-title: High myopia and glaucoma susceptibility the Beijing eye study publication-title: Ophthalmology doi: 10.1016/j.ophtha.2006.06.050 – volume: 126 start-page: 113 year: 2019 article-title: Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control publication-title: Ophthalmology doi: 10.1016/j.ophtha.2018.05.029 – volume: 90 start-page: 1207 year: 2013 article-title: Multifocal contact lens myopia control publication-title: Optom Vis Sci doi: 10.1097/OPX.0000000000000036 – volume: 98 start-page: 40 year: 2014 article-title: Defocus incorporated soft contact (disc) lens slows myopia progression in Hong Kong Chinese schoolchildren: a 2-year randomised clinical trial publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2013-303914 – volume: 379 start-page: 1739 year: 2012 article-title: Myopia publication-title: Lancet doi: 10.1016/S0140-6736(12)60272-4 – volume: 53 start-page: 7077 year: 2012 article-title: Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.12-10565 – ident: 2021031710251102000_bjophthalmol-2020-317664v1.17 doi: 10.1167/iovs.11-8453 – ident: 2021031710251102000_bjophthalmol-2020-317664v1.1 doi: 10.1016/S0140-6736(12)60272-4 – volume: 28 start-page: 142 year: 2014 ident: 2021031710251102000_bjophthalmol-2020-317664v1.7 article-title: Myopia, an underrated global challenge to vision: where the current data takes us on myopia control publication-title: Eye doi: 10.1038/eye.2013.256 – volume: 6 start-page: 133 year: 2015 ident: 2021031710251102000_bjophthalmol-2020-317664v1.10 article-title: Controlling myopia progression in children and adolescents publication-title: Adolesc Health Med Ther – ident: 2021031710251102000_bjophthalmol-2020-317664v1.13 doi: 10.1016/j.ophtha.2011.07.031 – ident: 2021031710251102000_bjophthalmol-2020-317664v1.9 doi: 10.1016/j.ophtha.2015.11.010 – ident: 2021031710251102000_bjophthalmol-2020-317664v1.18 doi: 10.1167/iovs.11-8005 – volume: 90 start-page: 1207 year: 2013 ident: 2021031710251102000_bjophthalmol-2020-317664v1.23 article-title: Multifocal contact lens myopia control publication-title: Optom Vis Sci doi: 10.1097/OPX.0000000000000036 – volume: 132 start-page: 258 year: 2014 ident: 2021031710251102000_bjophthalmol-2020-317664v1.19 article-title: Effect of bifocal and prismatic bifocal spectacles on myopia progression in children: three-year results of a randomized clinical trial publication-title: JAMA Ophthalmol doi: 10.1001/jamaophthalmol.2013.7623 – volume: 93 start-page: 344 year: 2016 ident: 2021031710251102000_bjophthalmol-2020-317664v1.22 article-title: Myopia control with bifocal contact lenses: a randomized clinical trial publication-title: Optom Vis Sci doi: 10.1097/OPX.0000000000000808 – volume: 324 start-page: 571 year: 2020 ident: 2021031710251102000_bjophthalmol-2020-317664v1.26 article-title: Effect of high add power, medium add power, or single-vision contact lenses on myopia progression in children: the blink randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2020.10834 – ident: 2021031710251102000_bjophthalmol-2020-317664v1.11 – ident: 2021031710251102000_bjophthalmol-2020-317664v1.16 doi: 10.1167/iovs.12-10565 – volume: 96 start-page: 556 year: 2019 ident: 2021031710251102000_bjophthalmol-2020-317664v1.24 article-title: A 3-year randomized clinical trial of MiSight lenses for myopia control publication-title: Optom Vis Sci doi: 10.1097/OPX.0000000000001410 – ident: 2021031710251102000_bjophthalmol-2020-317664v1.3 doi: 10.1111/j.1475-1313.2011.00886.x – ident: 2021031710251102000_bjophthalmol-2020-317664v1.21 doi: 10.1136/bjophthalmol-2013-303914 – ident: 2021031710251102000_bjophthalmol-2020-317664v1.5 doi: 10.1111/opo.12082 – ident: 2021031710251102000_bjophthalmol-2020-317664v1.12 doi: 10.1016/j.ophtha.2006.05.062 – ident: 2021031710251102000_bjophthalmol-2020-317664v1.25 doi: 10.1136/bjophthalmol-2018-313739 – ident: 2021031710251102000_bjophthalmol-2020-317664v1.20 doi: 10.1167/iovs.11-7260 – ident: 2021031710251102000_bjophthalmol-2020-317664v1.2 doi: 10.1016/j.ophtha.2016.01.006 – ident: 2021031710251102000_bjophthalmol-2020-317664v1.15 doi: 10.1016/j.ophtha.2018.05.029 – ident: 2021031710251102000_bjophthalmol-2020-317664v1.6 doi: 10.1016/j.ophtha.2006.06.050 – ident: 2021031710251102000_bjophthalmol-2020-317664v1.4 doi: 10.1016/S0161-6420(01)01024-7 – ident: 2021031710251102000_bjophthalmol-2020-317664v1.8 doi: 10.2471/BLT.12.104034 – ident: 2021031710251102000_bjophthalmol-2020-317664v1.14 doi: 10.1089/jop.2015.0043 |
| SSID | ssj0002617 |
| Score | 2.666586 |
| Snippet | AimsTo determine myopia progression in children who continued to wear the defocus incorporated multiple segments (DIMS) lenses or switched from single vision... To determine myopia progression in children who continued to wear the defocus incorporated multiple segments (DIMS) lenses or switched from single vision (SV)... |
| SourceID | pubmedcentral proquest pubmed crossref bmj |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1110 |
| SubjectTerms | Age Child child health (paediatrics) Child, Preschool China - epidemiology Clinical Science clinical trial Data collection Disease Progression Eyeglasses Follow-Up Studies Humans Myopia Myopia - therapy Optometry Pediatrics Refraction, Ocular Variance analysis |
| Title | Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study |
| URI | https://bjo.bmj.com/content/106/8/1110.full https://bjo.bmj.com/content/early/2021/03/17/bjophthalmol-2020-317664.full https://www.ncbi.nlm.nih.gov/pubmed/33731364 https://www.proquest.com/docview/2693154611 https://www.proquest.com/docview/2502809190 https://pubmed.ncbi.nlm.nih.gov/PMC9340033 |
| Volume | 106 |
| WOSCitedRecordID | wos000728111500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1468-2079 dateEnd: 20250607 omitProxy: false ssIdentifier: ssj0002617 issn: 0007-1161 databaseCode: 7X7 dateStart: 19220101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1468-2079 dateEnd: 20250607 omitProxy: false ssIdentifier: ssj0002617 issn: 0007-1161 databaseCode: BENPR dateStart: 19220101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELbYLUJceD8WSmUkDiARtY4T2-GCeLSCw64q6GFvkZ_sVtskNLug_gl-M2PH2XZBQitxySHx-JGZscf2zDcIvaAmVWAG8eTAgZJnTBSJVHkODDEMdgeZTJ0IySb4ZCKm0-I4Hri10a2ynxPDRG1q7c_I91NWUFjuGSFvm--Jzxrlb1djCo0B2vFIZdkQ7bw_nBx_Wc_FHm-8M4B5QsC46X15KNtXp3UzW87k4qxeQNdCIDFnHnlgoM5ON5epv2zPP10or6xJR7f_dzR30K1ojeJ3nfjcRddsdQ_dGMf79vvo1_iibuYSR4d23Hl_4NphY12tVy324A4dFrI1uPdOxK39FkLn8MuPn8dfX-EQzymhCQyLnCfCPm-3bS3ug8nfYNj3A3nrK5eYJheggtiBlNY_k1WDAwzuA3RydHjy4VMSMzgkKqd8mTCWalLkqbNFyrjObK6Is8QK4UQK0uMk1blJKeVKMkNyeWCJVlRL44wgnD5Ew6qu7GOEeW4scUo4MGcy5qSSQhqo12lmCbwZoQS4VkYFbMuwt6GsvMrl0nO57Lg8Qq99-aaD9NiiOO_FodQRPN3n8FhsQUnWlNu3tttLzeWILkVmhJ6vP8Nk4G94ZGXrFZTJ_U15AUbeCD3qBHTdKPxkCo36oWyI7rqABxrf_FLNZwFwvKCZz_n35N_deopupj42JHhH7qLh8nxln6Hr-sdy3p7voQGf8vAUe1FLfwNoC0ci |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1fb9MwELe2gYAX_rMVBhgJJJCwNtuJnSAhhBjTqq0VEn3oW-TENu3UJaFpmfol-CZ8R85O0q0gob7sgdfEf-LL3fmc_O53CL3kmqUQBkmyb8HIAxHFRKVhCC9ECzgdBIrZyBebkP1-NBzGXzbQrzYXxsEqW5_oHbUuMveNfI-JmMN2Lyj9UH4nrmqU-7valtCo1eLYLM7hyFa97x7A-33F2OHnwacj0lQVIGnI5YwIwTIah8yamAmZBSZMqTXURJGNGKzIKp6FmnEuUyU0DdW-oVnKM6WtjqjkMOwmugZuXDoEmRwuz3ee3LyOtiWhEEm1wCEu9tLTohzNRmpyVkxADj5rWQpHc7CZnp2u7ol_Bbp_4jUvbYCHd_4z0d1Ft5tIG3-sTeMe2jD5fXSj12AJHqCfvUVRjhVuwPq4RrbgwmJtbJHNK-yIK2qeZ6Nxi7zElfnm0wLx64Nu7-sb7HNVFUyBYQN3nbCrSW4qg9tE-Xd4airoXrnBFeZkAcLAFiywOCfzEnuK34docBXCeIS28iI3OwjLUBtq08hCqBYIq1IVKQ3j2kwYClc6iICSJI1zqRJ_buMiuaxUiVOqpFaqDnrr2pc1XckazWWrfUnWEMO7-iSTNXrSZc_1Z9ttlfRiRRca2kEvlrfB0bm_Vyo3xRzahA4FEEMA20HbtT0sJwUhc5jULWXFUpYNHIn66p18PPJk6jEPXD3Dx_9-rOfo5tGgd5KcdPvHT9At5nJgPAp0F23NpnPzFF3PfszG1fSZdwkYJVdsR78Bx32ivg |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFD7aOjTxwv1SGGAkkEBa1NlO7AQJIaCrqEarCvawt8iJbdqpa0rTMvVP8H_4dxzn0q0gob7sgdf4Fp-cm-PvnAPwgmuWoBskvQOLQu6LMPJUEgT4QbTA04GvmA2LYhOy3w9PTqLBFvyqY2EcrLLWiYWi1lnq_pG3mIg4mntBactWsIhBu_Nu-t1zFaTcTWtdTqNkkSOzPMfjW_6228Zv_ZKxzuHxx09eVWHASwIu554QLKVRwKyJmJCpb4KEWkNNGNqQ4e6s4mmgGecyUULTQB0YmiY8VdrqkEqO027DjkQfI2jAzofD_uDLygy4VOel7y09in5VDSPiopWcZtPhfKjGZ9kYqVLEMEvhkh5sJ2en6xbyL7f3T_TmJXPYufkfE_IW3Kh8cPK-FJrbsGUmd2C3V6EM7sLP3jKbjhSpYPykxLyQzBJtbJYucuJSWpQZoI0mNSaT5OZbETBIXrW7va-vSRHFqnAJgqbdDSKuWrnJDalD6N-QmclxeO4mV4R7SyQGsSib2bm3mJIi-e89OL4KYtyHxiSbmIdAZKANtUlo0YnzhVWJCpXGeW0qDMUnTfCQYeJK7eRxcaLjIr7MYLFjsLhksCbsu_7TMpHJBt1lzYlxWqWMd5VLxhuMpKuRm6-2VzPsxY4uuLUJz1fNqALdvZaamGyBfQKHD4jQtW3Cg1I2VosikTku6rayJjWrDi69-nrLZDQs0qxH3HeVDh_9-7WewS6KT_y52z96DNeZC44p4KF70JjPFuYJXEt_zEf57GmlHwjEVyxIvwFcEaze |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Myopia+control+effect+of+defocus+incorporated+multiple+segments+%28DIMS%29+spectacle+lens+in+Chinese+children%3A+results+of+a+3-year+follow-up+study&rft.jtitle=British+journal+of+ophthalmology&rft.au=Lam%2C+Carly+SY&rft.au=Tang%2C+Wing+Chun&rft.au=Lee%2C+Paul+H&rft.au=Zhang%2C+Han+Yu&rft.date=2022-08-01&rft.pub=BMJ+Publishing+Group+Ltd&rft.issn=0007-1161&rft.eissn=1468-2079&rft.volume=106&rft.issue=8&rft.spage=1110&rft.epage=1114&rft_id=info:doi/10.1136%2Fbjophthalmol-2020-317664&rft_id=info%3Apmid%2F33731364&rft.externalDBID=bjo&rft.externalDocID=bjophthalmol |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1161&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1161&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1161&client=summon |